Clinical Trial Management - software & AI news

Daily news on software, AI, and companies shaping clinical trial management.

Showing 118 results
Press release cover image

Aug 31, 2026

Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research

Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes.- Picture is available at AP -MELBOURNE, Australia, Aug. 31, 2026 /PRNewswire/ -- Monash Health, the largest public health service in Victoria, Australia, has signed a Memorandum of Understanding (MoU) with Data4Life, an international nonprofit digital health organization funded
Press release cover image

Aug 31, 2026

Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-makingBURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new cap
A clinical trial vial on a lab bench with an AI simulation model in the background.

Aug 29, 2026

HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation

HiRO and Differentia Biotech have entered into a strategic partnership aimed at revolutionizing clinical trial design through advanced AI-driven simulation technologies.The Memorandum of Understanding (MOU) establishes a framework for collaborative development of simulation capabilities that address significant challenges faced by biotech companies, particularly in the context of rising trial costs and compressed timelines. This partnership merges HiRO's extensive experience in global clinical o
Press release cover image

Aug 28, 2026

HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation

Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilitiesThe partnership unites global clinical operations excellence with advanced digital twin technology, delivering simulation-first drug development to biotech sponsors navigating an era of compressed timelines and escalating trial costs.SOMERSET, N.J., Aug. 28, 2026 /PRNewswire/ -- At a time when biopharma R&D productivity is declining and the cost of bringing a single drug to mark
Press release cover image

Aug 27, 2026

Velocity Clinical Research Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection

Centralized data model cuts industry-standard entry times by 80% with 99% confirmed accuracySponsors receive rapid access to clinical data and resolved queries for faster decision making DURHAM, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the world's largest integrated global site network, today announced that its centralized Electronic Data Capture (EDC) model is now entering 97% of clinical trial data within one business day of patient visits — two to four days faster
Press release cover image

Aug 25, 2026

Beyond good intentions: What new industry research reveals about the patient-centricity gap in clinical trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn what new industry research, conducted by Everest Group, reveals about the gap between patient-centric goals and the realities of clinical trial delivery. The featured speakers will discuss where patient journeys still break down, how fragmented technology can increase site burden and what the data shows about the impact of patient-centric platforms. Attendees will also explore steps sponsors and CROs can take across technology, people and processes to improve patient-
A minimalist representation of a brain with a psilocybin molecule, symbolizing Alzheimer's research.

Aug 20, 2026

Rhelion Life Sciences Corp.: Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease Trial Design

Rhelion Life Sciences Corp. has announced a collaboration through its subsidiary, Filament Health, with Darmiyan, Inc. to leverage Darmiyan's FDA-authorized BrainSee AI imaging platform in the context of Alzheimer’s disease clinical trials.This partnership aims to utilize the BrainSee platform, which predicts the progression of Alzheimer's in patients with amnestic mild cognitive impairment (aMCI), alongside Darmiyan's Virtual Microscope technology. The collaboration focuses on enhancing the ide
Press release cover image

Aug 20, 2026

TrialAssure Achieves ISO 27001:2022 Certification as Demand Grows for Trusted AI in Drug Development

CANTON, Mich. (August 20, 2026) –TrialAssure, a leading technology provider advancing clinical trialtransparency, disclosure, and data sharing, today announced it has achievedISO/IEC 27001:2022 certification for its Information Security Management System(ISMS), further strengthening the company’s commitment to delivering secure,trusted technology across its growing portfolio of AI life science softwaresolutions.ISO/IEC 27001:2022 is theinternationally recognized standard for ISMS and provides a
Press release cover image

Aug 20, 2026

Mednet Launches NCI SBIR/STTR-Funded TrialMatch to Accelerate Cancer Clinical Trial Discovery

AI-powered TrialMatch helps oncologists discover relevant trials faster by bringing trials to physicians where treatment decisions happen.NEW YORK, Aug. 20, 2026 /PRNewswire/ -- Mednet today announced TrialMatch, a clinical trial discovery tool designed to help oncologists identify relevant cancer trials in minutes instead of hours. Developed through a $2 million contract awarded by the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) / Small Business Technology Transfer
Press release cover image

Aug 19, 2026

AG Mednet Enhances Clinical Trial Collaboration and Compliance with Microsoft Office Integration

Sponsors, CROs, AROs, sites and committees can now work on familiar Microsoft Office documents inside the secure Judi platform, with no offline copies, no crossed versions and less opportunity for accidental PHI exposure.BOSTON, Aug. 19, 2026 /PRNewswire/ -- AG Mednet today announced Microsoft Office integration in Judi, its clinical trial optimization platform. Charters, meeting minutes, memos and other trial documents can now be created, edited and co-authored in Word, Excel and PowerPoint dir
A flat design of a drug compound silhouette against a solid background.

Aug 19, 2026

Medable, Tufts CSDD value AI gain at $21m net per programme

A recent collaboration between Medable and the Tufts Center for the Study of Drug Development (CSDD) reveals that AI-driven clinical monitoring can significantly enhance drug development efficiency, yielding financial benefits of up to $21 million per program and an impressive return on investment of 82 times.This analysis sought to quantify the economic impact of AI in clinical trials, specifically focusing on Medable's Clinical Monitoring Agent. By leveraging operational data from oncology tri
Press release cover image

Aug 19, 2026

Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors

Combined operations deliver unified U.S. and European trial delivery, faster recruitment, and expanded evidence-generation capabilities across pharma, biotech, medtech, diagnostics, and digital health.BOSTON, Aug. 18, 2026 /PRNewswire/ -- Curavit Clinical Research, an innovative clinical research organization (CRO) and Remote Clinical Site, today announced the acquisition of the CRO assets of Lindus Health. This transaction follows Lindus shifting focus to developing its own pipeline of therapeu